[REFERENCES]
1. Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005 Apr;128(4 Suppl 1):S79-86. 2. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad Gastroenterol. 2019;14(1):26–38. 3. Loehr WJ, Mujahed Z, Zahn FD, Gray GF, Thorbjarnarson B. Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg. 1969 Aug;170(2):232–8. 4. Sapkota S, Shaikh H. Non-Hodgkin Lymphoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. 5. GOUGH KR, READ AE, NAISH JM. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut. 1962 Sep;3(3):232–9. 6. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. 2005 Jan;54(1):54–9. 7. Hong YS, Woo YS, Park G, Lee K, Kang SH, Lee HW, et al. Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series. Gut Liver. 2016 Jan;10(1):147–51. 8. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003 Jul 14;163(13):1566–72. 9. Fairley NH, Mackie FP. Clinical and Biochemical Syndrome in Lymphadenoma. Br Med J. 1937 Feb 20;1(3972):375-404.4. 10. O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, et al. Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J Clin Res Ed. 1986 Oct 11;293(6552):908–10. 11. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011 May 12;117(19):5019–32. 12. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project. Blood. 2011 Jul 7;118(1):148–55. 13. Zhang JC, Wang Y, Wang XF, Zhang FX. Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review. OncoTargets Ther. 2016;9:863–8. 14. Weltgesundheitsorganisation. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. Lyon: International Agency for Research on Cancer; 2017. 585 p. (World Health Organization classification of tumours). 15. Ondrejka S, Jagadeesh D. Enteropathy-Associated T-Cell Lymphoma. Curr Hematol Malig Rep. 2016 Dec;11(6):504–13. 16. Verbeek WHM, Van De Water JMW, Al-Toma A, Oudejans JJ, Mulder CJJ, Coupé VMH. Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol. 2008 Jan;43(11):1322–8. 17. Ghimire P. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011;17(6):697. 18. Meijer JWR, Mulder CJJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol. 2004 Jan;39(241):78–84. 19. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center. J Clin Oncol. 2000 Feb 14;18(4):795–795. 20. Vaidya R, Habermann TM, Donohue JH, Ristow KM, Maurer MJ, Macon WR, et al. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013 Sep;24(9):2439–43.